Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02) - Concepedia

Concepedia

Publication | Open Access

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)

DOI Full Paper Access

92

Citations

14

References

2018

Year

Makoto Tahara, Naomi Kiyota, Tomoya Yokota, Yasuhisa Hasegawa, Kei Muro, Shunji Takahashi, Takuma Onoe, Akihiro Homma, Jun Taguchi, Motofumi Suzuki,

Annals of Oncology

Abstract

UMIN000010507.

References

	Year	Citations

Page 1